Delivery Order SPE2DB22D1106-SPE2DB25FEKY2
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,450.13 firm fixed-price delivery order is for the supply of the medication AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of April 11, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award, SPE2DB20D2104|SPE2DB25FMKTF, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,957.34 firm fixed price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTJY1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, has a ceiling value of $1,017.46 and a period of performance ending on April 9, 2025. It is a delivery order contract for the supply of the medication AIMOVIG 70 MG/ML AUTOINJECTORML. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, with ID SPE2DB25D3504|SPE2DB25FVUGT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,526.19 and a period of performance through April 16, 2025. It is a delivery order contract for the supply of the pharmaceutical product AIMOVIG 70 MG/ML AUTOINJECTORML. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, SPE2DB22D3004|SPE2DB25FQM14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,526.34 firm fixed-price delivery order is for the supply of the medication Aimovig 140 mg/ml autoinjector. The contract has an ultimate completion date of April 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,112.89 firm fixed-price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,441.30 firm fixed-price delivery order contract is for the supply of the medication Aimovig 140 mg/ml autoinjector. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,075.54 firm fixed-price delivery order contract, which has an ultimate completion date of January 21, 2025, is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDYDY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,744.36 Firm Fixed Price Delivery Order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML. The $5,897.50 firm-fixed-price delivery order has an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...